Advertisement
AZTA or IQV or MTD
Which Stock Would AI Choose? Azenta, Inc. (AZTA) vs. IQVIA Holdings Inc. (IQV) vs. Mettler-Toledo International Inc. (MTD) Stock Comparison
Key Takeaways
- Azenta (AZTA) has shown the strongest year-to-date performance with a 25% gain, outperforming peers amid life sciences sector volatility.
- IQVIA Holdings (IQV) faces recent downward pressure despite in-line earnings and AI initiatives, down 30% year-to-date.
- Mettler-Toledo (MTD) exhibits modest declines year-to-date at 9%, with challenges in revenue growth but stable analyst outlook.
- All three operate in healthcare, focusing on instruments and diagnostics, but AZTA offers higher relative upside potential per analyst targets.
- Analyst price targets suggest 40-60% upside for AZTA, 45% for IQV, and about 15% for MTD.
- Recent market sentiment reflects sector headwinds, with AZTA demonstrating greater resilience in recent weeks.
Introduction
Azenta (AZTA), IQVIA Holdings (IQV), and Mettler-Toledo International (MTD) are key players in the healthcare sector, providing essential tools, data analytics, and precision instruments to life sciences and pharmaceuticals. This stock comparison analyzes their recent performance, business drivers, and market positioning amid evolving sector dynamics. Traders seeking short-term momentum and investors focused on long-term growth in diagnostics and research may find value in understanding their relative strengths, valuation sensitivities, and sentiment shifts in the current market environment.
AZTA Overview and Recent Performance
Azenta, Inc. (AZTA) specializes in semiconductor-based solutions and life sciences equipment, serving semiconductor manufacturing and biopharma storage needs. With a market capitalization of approximately $1.15 billion, the stock trades around $25, near the lower end of its 52-week range of $20 to $42. In recent market activity, AZTA has gained over 25% year-to-date, buoyed by resilience in core segments despite mixed quarterly results that pressured shares in after-hours trading. Sentiment has been influenced by broader life sciences demand and analyst adjustments, with an average price target of $35 indicating potential upside. Volatility persists due to exposure to cyclical semiconductor demand within biotech applications.
IQV Overview and Recent Performance
IQVIA Holdings Inc. (IQV) is a leading provider of clinical research, data analytics, and technology solutions for the life sciences industry. Boasting a $26.5 billion market cap, shares hover near $158, within a 52-week range of $135 to $247. Recent weeks have seen downward momentum, with year-to-date declines exceeding 30%, exacerbated by AI-related concerns despite in-line earnings and launches like IQVIA.ai with NVIDIA. Upcoming quarterly results and a shelf registration for share issuance have tempered sentiment, though analysts maintain an average target of $230, reflecting confidence in revenue growth around 6% and EPS expansion.
MTD Overview and Recent Performance
Mettler-Toledo International Inc. (MTD) manufactures precision instruments and end-of-line solutions for laboratory, industrial, and food sectors. The company holds a $25.7 billion market cap, with shares at about $1,267 in a 52-week range of $1,052 to $1,525. Recent performance shows year-to-date softness at 9% lower, driven by modest revenue growth and elevated valuations ahead of earnings. Market sentiment reflects caution on returns on capital amid competitive pressures, yet analyst targets averaging $1,460 suggest moderate upside, supported by steady demand for analytical instruments.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases 25 top-performing AI trading bots curated from over 350 available bots that trade thousands of tickers across diverse strategies, timeframes, and market conditions. These bots feature impressive stats, including annualized returns up to 163%, win rates from 51% to 88%, profit factors reaching 11.7, and profit-to-drawdown ratios as high as 17. Examples include the USAR/SMR/CIFR Volatility Bot at 163% return and 75% win rate, and Semiconductor bots with 97% returns. Designed for copy trading with real-time signals, virtual risk management, and customizable options, they cater to various styles like trend following, volatility plays, and sector themes. Explore these bots to enhance your trading with data-driven insights tailored to current markets.
Head-to-Head Comparison
AZTA, IQV, and MTD share healthcare exposure but diverge in business models: AZTA emphasizes equipment manufacturing, IQV focuses on data-driven services (P/E ratio (price-to-earnings ratio) around 20), and MTD leads in precision hardware. Growth drivers include life sciences demand for AZTA and MTD, versus clinical trials analytics for IQV. Recent momentum favors AZTA's YTD gains over peers' declines, though IQV and MTD offer scale stability. Risk factors encompass cyclicality for AZTA, leverage for IQV, and growth slowdowns for MTD. Valuation sensitivity is highest for smaller AZTA, with market sentiment tilting toward its recovery potential amid sector rotation.
Tickeron AI Verdict
Tickeron’s AI currently favors AZTA due to its superior year-to-date trend consistency, substantial analyst upside, and resilient positioning in life sciences equipment relative to peers' recent softness. While IQV shows promise from AI catalysts and MTD stability, AZTA's momentum suggests higher probability of near-term outperformance in the current environment.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AZTA’s FA Score shows that 0 FA rating(s) are green whileIQV’s FA Score has 0 green FA rating(s), and MTD’s FA Score reflects 1 green FA rating(s).
- AZTA’s FA Score: 0 green, 5 red.
- IQV’s FA Score: 0 green, 5 red.
- MTD’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AZTA’s TA Score shows that 5 TA indicator(s) are bullish while IQV’s TA Score has 6 bullish TA indicator(s), and MTD’s TA Score reflects 4 bullish TA indicator(s).
- AZTA’s TA Score: 5 bullish, 5 bearish.
- IQV’s TA Score: 6 bullish, 3 bearish.
- MTD’s TA Score: 4 bullish, 6 bearish.
Price Growth
AZTA (@Pharmaceuticals: Other) experienced а -16.73% price change this week, while IQV (@Medical Specialties) price change was -5.37% , and MTD (@Medical Specialties) price fluctuated -8.25% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.52%. For the same industry, the average monthly price growth was -4.78%, and the average quarterly price growth was +19.71%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +10.58%. For the same industry, the average monthly price growth was +4.66%, and the average quarterly price growth was -5.70%.
Reported Earning Dates
AZTA is expected to report earnings on Aug 11, 2026.
IQV is expected to report earnings on Jul 28, 2026.
MTD is expected to report earnings on Jul 23, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-4.52% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical Specialties (+10.58% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| AZTA | IQV | MTD | |
| Capitalization | 738M | 28.2B | 20.8B |
| EBITDA | 36.6M | 3.52B | 1.24B |
| Gain YTD | -51.879 | -24.972 | -26.004 |
| P/E Ratio | 42.43 | 21.01 | 24.23 |
| Revenue | 596M | 16.6B | 4.03B |
| Total Cash | 381M | 2.1B | 66.9M |
| Total Debt | 55.7M | 16.1B | 2.15B |
AZTA | IQV | MTD | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 54 | 12 | 52 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 67 Overvalued | 66 Overvalued | 99 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | 100 | |
SMR RATING 1..100 | 93 | 42 | 3 | |
PRICE GROWTH RATING 1..100 | 93 | 58 | 65 | |
P/E GROWTH RATING 1..100 | 84 | 37 | 65 | |
SEASONALITY SCORE 1..100 | 50 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IQV's Valuation (66) in the Servicestothe Health Industry industry is in the same range as AZTA (67) in the Electronic Production Equipment industry, and is somewhat better than the same rating for MTD (99) in the Medical Specialties industry. This means that IQV's stock grew similarly to AZTA’s and somewhat faster than MTD’s over the last 12 months.
IQV's Profit vs Risk Rating (100) in the Servicestothe Health Industry industry is in the same range as AZTA (100) in the Electronic Production Equipment industry, and is in the same range as MTD (100) in the Medical Specialties industry. This means that IQV's stock grew similarly to AZTA’s and similarly to MTD’s over the last 12 months.
MTD's SMR Rating (3) in the Medical Specialties industry is somewhat better than the same rating for IQV (42) in the Servicestothe Health Industry industry, and is significantly better than the same rating for AZTA (93) in the Electronic Production Equipment industry. This means that MTD's stock grew somewhat faster than IQV’s and significantly faster than AZTA’s over the last 12 months.
IQV's Price Growth Rating (58) in the Servicestothe Health Industry industry is in the same range as MTD (65) in the Medical Specialties industry, and is somewhat better than the same rating for AZTA (93) in the Electronic Production Equipment industry. This means that IQV's stock grew similarly to MTD’s and somewhat faster than AZTA’s over the last 12 months.
IQV's P/E Growth Rating (37) in the Servicestothe Health Industry industry is in the same range as MTD (65) in the Medical Specialties industry, and is somewhat better than the same rating for AZTA (84) in the Electronic Production Equipment industry. This means that IQV's stock grew similarly to MTD’s and somewhat faster than AZTA’s over the last 12 months.
| AZTA | IQV | MTD | |
|---|---|---|---|
| RSI ODDS (%) | 2 days ago 73% | N/A | 2 days ago 75% |
| Stochastic ODDS (%) | 2 days ago 71% | 2 days ago 68% | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 85% | 2 days ago 61% | 2 days ago 62% |
| MACD ODDS (%) | 2 days ago 87% | 2 days ago 67% | 2 days ago 67% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 63% | 2 days ago 63% |
| TrendMonth ODDS (%) | 2 days ago 82% | 2 days ago 70% | 2 days ago 66% |
| Advances ODDS (%) | 9 days ago 70% | 9 days ago 58% | 11 days ago 63% |
| Declines ODDS (%) | 2 days ago 82% | 2 days ago 65% | 4 days ago 63% |
| BollingerBands ODDS (%) | 2 days ago 76% | 2 days ago 77% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 76% | 2 days ago 51% | 2 days ago 68% |
Advertisement
AZTA and
Correlation & Price change
A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with XRAY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then XRAY could also see price increases.
| Ticker / NAME | Correlation To AZTA | 1D Price Change % | ||
|---|---|---|---|---|
| AZTA | 100% | -4.73% | ||
| XRAY - AZTA | 63% Loosely correlated | -3.27% | ||
| IQV - AZTA | 60% Loosely correlated | -0.91% | ||
| RVTY - AZTA | 59% Loosely correlated | -2.50% | ||
| A - AZTA | 59% Loosely correlated | -1.38% | ||
| MTD - AZTA | 59% Loosely correlated | -0.99% | ||
More | ||||
MTD and
Correlation & Price change
A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.
| Ticker / NAME | Correlation To MTD | 1D Price Change % | ||
|---|---|---|---|---|
| MTD | 100% | -0.99% | ||
| A - MTD | 75% Closely correlated | -1.38% | ||
| TMO - MTD | 70% Closely correlated | -2.20% | ||
| DHR - MTD | 67% Closely correlated | -1.60% | ||
| BRKR - MTD | 67% Closely correlated | -2.90% | ||
| AZTA - MTD | 61% Loosely correlated | -4.73% | ||
More | ||||